ArticleCancer chemotherapy and pharmacology2020

Evaluation of gefitinib systemic exposure in EGFR-mutated non-small cell lung cancer patients with gefitinib-induced severe hepatotoxicity.

Takahisa Kawamura et al.PubMed ↗Publisher ↗

No numbers read from the abstract.